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Electro acoustic stimulation of the auditory system: UNICAMP’s
surgical approach
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A new era has arrived in auditory rehabilitation with the introduction of new technologies 
such as electroacoustic stimulation (EAS). EAS is indicated for patients with residual hearing at 
low frequencies and severe or profound hearing loss at high frequencies. These patients have no 
indication for conventional cochlear implant and have difficulties in adapting to individual sound 
amplification devices. Preservation of hearing is vital in this process; the surgical technique must 
be based on this concept.
Objectives: To present the cochlear implant surgical technique with MED-EL Mand FlexEAS to 
preserve hearing in patients with hearing loss at high frequencies and to maintain low frequency 
hearing. We are the first institution to carry out this treatment in Brazil. 
Methods: A case report of the surgical technique carried out in four patients; the procedure was 
carried out by the cochlear implant group of a specialized clinical hospital. 
Results: The procedures were successful and uneventful. 
Conclusion: We described the technique used at our institution for implants using EAS; the surgical 
technique is complex and includes steps for preservation of hearing. 
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INTRODUCTION
Just over a decade ago patients with sensorineural 
hearing loss had few options for auditory rehabilita-
tion; there were hearing aids or sound amplification 
devices, electrical stimulation of the cochlear nerve 
(cochlear implants)1-5, and electric stimulation of the 
brainstem (brainstem implant). Mild or moderate cases 
may benefit from hearing aids; cochlear implants have 
been considered the gold standard for rehabilitating 
severe or profound dysacusis3,4,6-8. Brainstem implants 
are an alternative for patients in which cochlear implants 
are not indicated. Some patients, however, remained in 
an “intermediate zone” in which hearing aids yielded 
no benefits and the criteria for cochlear implants were 
not met2,3.
These patients often present sloping hearing loss 
where low frequency thresholds (up to 1,000 Hz) are 
preserved and higher frequency thresholds are lower, 
with severe or profound hearing loss at middle and high 
frequencies. A new form of therapy arose as the concept 
of auditory preservation developed and technological 
advances were made in cochlear implants, namely elec-
tric acoustic or hybrid stimulation2,9-13.
Knowing about the diseases that cause hearing 
loss is fundamental to help patients by facilitating and 
speeding auditory rehabilitation processes14. Stimulating 
the auditory system is essential for better communica-
tion15.
Christian Von Ilberg developed the concept of 
electric acoustic stimulation (EAS) in 1999 2,16-18. The idea 
behind EAS is the possibility of synergy by associating 
conventional cochlear implants (electric stimulation) and 
individual hearing aids (acoustic stimulation) in the same 
ear. This opened possibilities for treating patients with 
residual hearing at low frequencies only, which did not 
benefit significantly from hearing aids2,10,12,13,16-18.
The possibility of preserving residual hearing 
following cochlear implant surgery arose with the work 
of Lenarz; these patients respond better to hybrid sti-
mulation of hearing – electric (cochlear implant) and 
acoustic (hearing aid)3,11. Benefits occur mainly in dis-
crimination of sound in noisy environments7,19,20.
Several surgical techniques for preserving hearing 
have been described2,10,18,21. These techniques are refined 
by using specific drugs during these procedures, such 
as topical corticosteroids, antibiotics, and hyaluronic 
acid11. Another important point – already demonstrated 
in experimental work – is the approach for electrode in-
sertion during surgery11,22-24. Insertion by a cochleostomy 
anterior and inferior to the round window, or directly 
through the round window, are related to less intraco-
chlear trauma compared to the traditional cochleostomy; 
direct insertion through the round window appears to 
be the least traumatic approach1,2,18,21-23.
The intrinsic features of electrodes are important 
for reducing intracochlear trauma – the shape, length, 
and flexibility of the electrode arrays also help attain 
better results2,10,22-26. Gantz27 recently published a report 
on eight patients that underwent cochlear implant sur-
gery using a 10 mm electrode (Iowa Nucleus Hybrid 
Implant); the partial or total preservation rate of hearing 
was 96%. In 2004, MED-EL (Innsbruck, Austria) launched 
in the market a new thinner and more flexible 21 mm 
implant prototype27,28. Gstoettner reported high rates of 
partial or total hearing preservation by using the same 
prototype26-28.
The purpose of this study was to present our 
experience of four patients that underwent cochlear 
implant surgery with the MED-EL FlexEAS electrode. We 
describe the surgical technique for EAS with the MED-
EL Mand FlexEAS model, carried out by the Implantable 
Prostheses and Cochlear Implant Group, Otology Unit, 
of a tertiary care hospital, from March 2010 to May 2011.
MATERIAL AND METHODS
The protocol for selecting patients was the 
following:
1. Serial audiometry;
2. Free field audiometry;
3. Otoacoustic emissions (OAE) testing;
4. Speech perception test;
5. Brainstem auditory evoked potential (BAEP);
6. Computed tomography of the temporal bones;
7. Magnetic resonance imaging of the inner ear;
8. Phonoaudiological and psychological evalu-
ation.
The main criteria for indicating the procedure were:
a) Stable auditory thresholds within the past two 
years;
b) Speech perception test – (65 dB, with the best 
possible amplification): < 40%;
c) Prior experience with hearing aids;
d) Sensorineural type dysacuss29 according to the 
chart below (Figure 1):
Selection of Patients
Patients were selected based on the abovemen-
tioned criteria. All patients were informed about the 
indication for surgery, possible complications, objectives 
of therapy, and expected results. Patients were given a 
free informed consent form after detailed explanations.
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Ethics Committee
The institutional review board approved this 
study.
Inclusion criteria:
- Age over 18 years.
- Bilateral sensorineural dysacusis with little 
or no benefit from hearing aids.
- Pure tone thresholds better than 65 dB at 
125, 250, and 500 Hz, and worse than 85 dB at 
frequencies over 1,000 Hz.
- Auditory discrimination for monosyllables below 
40% at the best possible sound amplification.
- Stable hearing loss in at least the past two years.
Assessment
Before surgery, conventional audiometry, speech 
perception tests with and without hearing aids, OAE (oto-
acoustic emissions) testing, BAEP (brainstem auditory 
evoked potential), computed tomography and magnetic 
resonance imaging of the temporal bones were done in 
all patients. A psychological evaluation was carried out 
to discuss expectations about the implants.
Implants were activated 45 days after surgery. 
Postoperative audiometry and speech perception tests 
were carried out.
Implants
The implant that was used in these cases was the 
Med-El MAnd FLEXEAS TM (21 mm) (Figures 2 and 3)30. 
The purpose of the electrode is to reduce intracochle-
ar trauma during insertion as much as possible; thus, 
each set of electrodes has a wave-like wire configura-
tion, placed on the lateral wall, and having low channel 
density (Figure 3).
Figure 1.Chart showing an example of an expected audiogram in 
candidates for hybrid implants.11
Figure 3. Amplified schematic showing the wave shape of electrodes 
(sinus) in the silicone sheath with a wire structure.
Figure 2. Schematic representation of the Electrode Med-El MAnd 
FLEXEAS ™(21mm).
This project is ideal for insertion through the 
round window, a technique many otologic surgeons 
prefer because it is less traumatic. Premolded electrodes 
are more traumatic and are not easily inserted through 
the round window; they are therefore inadequate for 
preserving hearing. Many insertions were done through 
the scala vestibuli – rather than the scala tympani – with 
this type of electrode2,10,22-28.
Table 1 summarizes the technical data of the EAS 
cochlear implant.
Monitoring the facial nerve (VII cranial nerve)
The 8th cranial nerve is monitored throughout the 
procedure. Electrodes are attached to the ipsilateral rami 
of the operated ear on the frontal, zygomatic, buccal, and 
mandibular areas; there is also a ground electrode atta-
ched onto the patient’s thorax and a reference electrode 
(STIM1 +, positive pole) for the stimulatory pen (STIM 1 
-, negative pole) that is attached to the sternoclavicular 
area. We use a NIM-PulseTM (Nerve Integrity Monitor, 
Meditronic XomedTM).
Microscope
Microscopy is essential and has revolutionized 
otologic procedures. We use a CARL ZEISS GMGH S88 
Microscope™ with a camera and a digital video system 
for recording the procedures.
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Figure 4. Representative drawing of surgical landmarks to the left (tip 
of the mastoid, temporal line, retroauricular incision area, area of the 
internal component, and microphone area with a mock-up).
RESULTS
Description of the surgery
A patient is placed on horizontal dorsal decu-
bitus with the head turned to the contralateral side. 
General anesthesia with orotracheal intubation is done. 
The operative field is prepared by ample trichotomy, 
antisepsis with 2% chlorhexidine, and placement of 
electrodes for monitoring the 8th cranial nerve. The 
operative field is separated from the rest of the scalp by 
using microporeTM. Antibiotic prophylaxis is done with 
endovenous cefazolin (50 mg/kg) during induction of 
anesthesia.
Table 1. Technical specifications of the Med-El MAnd FLEXEAS 
cochlear implant
Model: SONATAti100 ELECTRODE FLEXEAS
Material: TITANIUM AND SILICONE
Removable magnet NO
Size
Length: 45.7 mm
Width: 24.8 mm
Thickness: 5.9 mm
Weight: 8.6g
Receiver well for the internal unit
Diameter: 24.8 x 17.4 (mm 
x mm)
Depth: 2 mm
Electrode array
Perimodiolar: no
Straight: yes
Dimensions of electrode array
Total length of electrode ar-
ray: 24 mm
Length of electrodes that 
remain within the cochlea: 
20.9 mm
Length of active electrodes: 
20.9 mm
Number of electrodes: 12 
channels (19 electrodes – 5 
apex channels are not double 
for residual preservation)
Apex: electrode number 1 
(number of the most apical 
electrode).
Base: electrode number 12
Diameter of electrode array 
on the apex: 0.3 mm
Diameter of electrode array 
on the base: 0.8 mm
Diameter of the cochleos-
tomy: 1.3 mm
Allow MR
yes
Technical specifications: 0.2T, 
1.0T e 1.5T 
Please, fill out the questionnaire and prior instructions from Med El.
1. The main landmarks are marked: tip of the 
mastoid, temporal line, retroauricular incision 
line, area of the internal component, and area 
of the microphone with the help of a mock-
up (Figure 4);
2. Antisepsis with 0.2% aqueous chlorhex-
idine, placement of sterile drapes and 
steri-drape™2 (Figure 1);
3. Rectilinear retroauricular incision and dis-
section along anatomical planes. Preparation 
of a “cross” Palva flap (periosteal muscle) 
raising the four segments of the flap over the 
subperiosteal plane;
4. Removal of small fragments of fascia and 
temporal muscle to occlude the cochleostomy;
5. Simple mastoidectomy, identifying the lateral 
semicircular canal, the short ramus of the an-
vil, the posterior wall of the outer ear canal, 
the tegmen timpani, and the lateral sinus. 
Gathering a small amount of bone dust;
6. Thinning of the posterior wall of the outer ear 
canal, posterior tympanostomy, preservation 
of the incus buttress;
7. Preparation of the receiver well for the inner 
component of the intracochlear EAS on the 
squamous portion of the temporal bone (well) 
using a specific mock-up;
8. Irrigation of the cavity with povidone-iodine 
(10% povidone-iodine / 1% active iodine) for 
two minutes followed by abundant irrigation 
with lactated Ringer’s solution™ (Figure 5);
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Figure 5. Illustration of preparing the receiver well for the internal 
component of the EAS cochlear implant in the squamous portion of 
the temporal bone, with a specific mock-up;
Figure 6. Ilustration of irrigation of the mastoid cavity and middle ear 
with povidone-iodine solution (10% povidone-iodine / 1% active iodine).
Figure 7. Ilustration of irrigation of the mastoid cavity and the middle ear 
with antibiotic (4mg/ml ciprofloxacin).
9. Irrigation of the cavity with ciprofloxacin 
(4mg/ml) for two minutes followed by ir-
rigation with lactated Ringer’s solution™ 
(Figure 6); 
14. Preparation of the fascia graft; making a pi-
nhole central orifice to allow the electrode to 
pass snugly to be placed in the cochleostomy/
round window site;
15. Insertion of the electrode slowly and con-
tinuously during three minutes through the 
hole in the graft;
16. Positioning the muscle graft around the elec-
trode to seal the cochleostomy. Placing bone 
dust to close the posterior tympanotomy;
17. Positioning the ground electrode under the 
muscle-periosteum flap;
18. Closure with Vicryl™ 3.0 sutures on the Palva 
flap planes and subcutaneous tissue; skin 
closure with Nylon 4.0;
19. Cleaning of the patient and placing an exter-
nal compressive dressing;
20. Impedance testing, neural response telemetry 
(NRT), and a transorbital incidence radiogra-
ph are done to confirm the position of the 
intracochlear electrode.
Note: it is worth noting that this surgical technique 
was not created or developed by our tem. We adopted 
this approach based on the experience that our team 
had acquired in courses, conferences, and reading the 
specific medical literature.
DISCUSSION
Hearing rehabilitation through surgery (cochlear 
implant) with hearing preservation in patients with 
hearing remains in the low frequencies becomes a new 
treatment option2,9-11.
10. Endovenous administration of dexametha-
sone (8 mg) before approaching the middle 
ear via a cochleostomy or through the round 
window;
11. Application of topical triamcinolone (40mg/
ml) over the round window;
12. Opening the membrane of the round window; 
if this approach is impossible, the endosteous 
is opened by means of a cochleostomy;
13. Positioning the internal component on its 
well;
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Electrodes on the lateral wall are less traumatic 
than premolded electrodes; they are preferable because 
of this feature and to preserve residual hearing30.
Topical medication in the middle ear before plac-
ing an implant is a controversial topic; this concern, 
however, is justified. The purpose of using povidone-
iodine and ciprofloxacin is to assure that the operative 
field remains sterile so that contamination of the inner 
ear is avoided as much as possible, thereby avoiding 
possible damage to the inner hair cells. The purpose 
of corticosteroids topically over the round window and 
systemically is to reduce intracochlear inflammation, 
thereby minimizing damage to the round window.
There is a debate in the literature about the topi-
cal effect of endovenous drugs in the middle and inner 
ear31. The membranes of the oval and round windows 
are permeable to several substances; however, there is 
uncertainty about whether this change in administration 
route changes or not the pharmacodynamics of these 
drugs to the point of altering their expected effect in 
the inner ear32,33. The drug formulation, the carrier sub-
stance for crossing the membrane, the osmolarity of the 
solution, the duration of action/exposure of the drug in 
the inner ear among other factors are important issues 
for substances that penetrate the membranes to act in 
the inner ear31.
Bird et al. have shown that the concentration of 
drugs in the cochlear perilymph is higher compared to 
the blood plasma at dosages for endovenous concentra-
tions – such is the case of corticosteroids. These doses 
were measured in the cochlea and plasma based on 
equivalent endovenous dosages34,35.
The use of lactated Ringer’s solution through-
out the procedure, especially from the beginning of 
mastoidectomy, is justified because it is more similar 
to endolymph, which at least in theory reduces intra-
cochlear trauma.
The ossicular chain should be handled minimally; 
any disruption among ossicles should be avoided to 
preserve residual hearing; the ossicular chain can be 
compromised, which results in loss of conduction and 
reduced acoustic simulation. Any vibration of the os-
sicular chain may be conveyed to the inner ear and may 
cause cochlear injury, sensory loss, and further loss of 
residual hearing2,10,18,21,29.
Several authors consider the approach to elec-
trode insertion – cochleostomy or through the round 
window – as one of the most important steps to reduce 
intracochlear damage29. Burring and exposure of the 
inner ear should be done delicately. Cochleostomy in-
creases the risk of damage to the inner ear because burr-
ing in the cochleostomy site may cause fluid-mediated 
injury due to vibration of the periosteum. There may also 
be damage to soft tissues (spiral ligament, vascular stria, 
basilar membrane, Corti organ, Reissner membrane, etc.) 
and to bone (spiral bone lamina, modiolus, Rosenthal’s 
canal, etc.). The vascular stria is commonly damaged in 
conventional cochleostomy, which explains its worse 
results in hearing preservation. Opening the periosteum 
in cochleostomy and through the round window allows 
perilymph to exit, which disrupts the intracochlear he-
mostasis (especially the electrochemical gradient); there 
is also the possibility of trauma by inadvertent suction29.
Therefore, insertion of the electrode through a 
cochleostomy anterior and inferior to or directly through 
the round window is currently the method of choice; this 
approach increases the certainty of accessing the scala 
tympani and has a lower potential for cochlear trauma29.
Electrodes should be inserted slowly, continu-
ously, and at a constant rate. Rapid electrode insertion 
may cause fluid-mediated injury. Care should be taken 
not to introduce contaminants (blood, bone dust, se-
cretions) into the intracochlear compartment, which 
would increase local inflammation. Electrodes should 
fit snugly, but without resistance; care should be taken 
not to suction endolymph. There is an exponential in-
crease in resistance to progression after the electrode is 
inserted by about 15 mm. The electrode specifications, 
its material (it should be as inert as possible to minimize 
foreign body inflammation), flexibility, characteristics of 
the internal arrays, diameter, length, and others, are also 
important factors29.
The cochleostomy is sealed with a temporal fascia 
graft, which should not be too large so as not to affect 
the mobility of the ossicular chain and to avoid inflam-
mation from altering the middle ear homeostasis29.
The steps of surgery were planned to preserve 
residual hearing and to reduce cochlear injury as much 
as possible.
Although much has been said about EAS, this 
mode of therapy is rarely undertaken in Brazil. Our unit 
has pioneered this procedure in this setting, and not 
many such procedures have been done. We point out 
that cochlear manipulation surgery aiming to preserve 
hearing is difficult.
CONCLUSION
We described the technique for EAS implants as 
applied to the cases operated at our unit. This technique 
differs from conventional cochlear implant routine by 
including steps aiming at hearing preservation. The tech-
nique is complex and has nuances that make it difficult 
to carry out adequately.
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We believe that cochlear implants with hearing 
preservation opens a new era in otology and the reha-
bilitation of patients with hearing loss.
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